Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective study

Epilepsia

Volumn 55, Issue 11, 2014, Pages e125-e128

  Samsonsen, Christian ^a   Reimers, Arne ^a,b   Bråthen, Geir ^a,b   Helde, Grethe ^b   Brodtkorb, Eylert ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Adherence; Seizure; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; EMERGENCY CARE; EPILEPSY; FEMALE; FOCAL EPILEPSY; HOSPITALIZATION; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MONOTHERAPY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY; TONIC CLONIC SEIZURE; TREATMENT REFUSAL; ACUTE DISEASE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG MONITORING; EPILEPSY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84912119425     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12801     Document Type: Article

References (14)

1. World Health Organization. Adherence to long term therapies: evidence for action. Geneva: World Health Organization; 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence-report/en/. Accessed August 8, 2014.
2. Paschal AM, Hawley SR, St Romain T, et al. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 2008;49:1115-1122.
3. Faught E. Adherence to antiepilepsy drug therapy. Epilepsy Behav 2012;25:297-302.
4. Smithson WH, Hukins D, Colwell B, et al. Developing a method to identify medicines non-adherence in a community sample of adults with epilepsy. Epilepsy Behav 2012;24:49-53.
5. Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-1276.
6. Specht U, Elsner H, May TW, et al. Postictal serum levels of antiepileptic drugs for detection of noncompliance. Epilepsy Behav 2003;4:487-495.
7. Carpentier N, Jonas J, Frismand S, et al. Direct evidence of nonadherence to antiepileptic medication in refractory focal epilepsy. Epilepsia 2013;54:20-23.
8. Shah NM, Hawwa AF, Millership JS, et al. Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling. Epilepsia 2013;54:1020-1027.
9. Buck D, Jacoby A, Baker GA, et al. Factors influencing compliance with antiepileptic drug regimens. Seizure 1997;6:87-93.
10. Bryant SG, Ereshefsky L. Determinants of compliance in epileptic outpatients. Drug Intell Clin Pharm 1981;15:572-577.
11. Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002;3:338-342.
12. Sweileh WM, Ihbesheh MS, Jarar IS, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 2011;21:301-305.
13. Modi AC, Ingerski LM, Rausch JR, et al. White coat adherence over the first year of therapy in pediatric epilepsy. J Pediatr 2012;161:695-699.
14. Li J, Si Y, Hu J, et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia 2013;54:1988-1996.